FDA Criticized for Diabetes Drug Avandia

Morning Edition, May 22, 2007 · There are more demands to overhaul the Food and Drug Administration. Scientific analysis indicates the widely used diabetes drug, Avandia, raises the risk of heart attacks and possibly death. The agency is being criticized for the way the drug was initially approved, and for not reporting problems sooner.

E-mail this Page

Recipient's e-mail address:	» Up to twelve addresses, separated by commas.
Your e-mail address:
Your name:
Personal message (optional, 600 characters max):
Your NPR member station:
Are you a member of your local NPR station?	Yes No
Would you like to receive information from your local NPR member station? (see NPR's privacy policy)	Yes No
Please send me updates from NPR.	Yes No

(Information collected by NPR will be used solely for internal NPR or NPR member station purposes and only if you selected 'yes' above. See NPR's privacy policy for more information.)